Page 18 - Castle Biosciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Castle biosciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Castle Biosciences Today - Breaking & Trending Today

Castle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Castle Biosciences, Inc. , a company improving health through innovative tests that guide patient care, today announced that on Dec. 18, 2023, the Compensation Committee of its Board of Directors. ....

Castle Biosciences , Castle Biosciences Inc , Compensation Committee , Nasdaq Listing Rule , Mypath Melanoma ,

Short Interest in Castle Biosciences, Inc. (NASDAQ:CSTL) Drops By 9.2%

Short Interest in Castle Biosciences, Inc. (NASDAQ:CSTL) Drops By 9.2%
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

United States , Banque Pictet Cie , Derekj Maetzold , Castle Biosciences , Daniel Bradbury , Castle Biosciences Company Profile , Deutsche Bank , Castle Biosciences Inc , Vanguard Group Inc , American Century Companies Inc , Securities Exchange Commission , Walleye Capital , Get Free Report , Director Daniel Bradbury , Exchange Commission , Century Companies , Castle Biosciences Daily ,

Castle Biosciences, Inc. (NASDAQ:CSTL) Short Interest Update

Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) was the recipient of a significant decrease in short interest during the month of November. As of November 30th, there was short interest totalling 1,180,000 shares, a decrease of 9.2% from the November 15th total of 1,300,000 shares. Based on an average daily trading volume, of 253,300 […] ....

Castle Biosciences , Daniel Bradbury , Derekj Maetzold , Ensign Peak Advisors Inc , Securities Exchange Commission , Bluepath Capital Management , Lazard Asset Management , Royal Bank , Tower Research Capital , Castle Biosciences Inc , Get Free Report , Exchange Commission , Director Daniel Bradbury , Asset Management , Path Capital Management , Research Capital , Peak Advisors Inc , Castle Biosciences Daily , Nasdaq Cstl ,

Guggenheim Initiates Coverage on Castle Biosciences (NASDAQ:CSTL)

Guggenheim Initiates Coverage on Castle Biosciences (NASDAQ:CSTL)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Castle Biosciences , Daniel Bradbury , Derekj Maetzold , Citadel Advisors , Castle Biosciences Inc , Securities Exchange Commission , Bellevue Group , Granahan Investment Management , Deerfield Management Companylp Series , Castle Biosciences Company Profile , Millennium Management , Get Free Report , Marketbeat Ratings , Biosciences Stock Down , Director Daniel Bradbury , Exchange Commission , Investment Management , Castle Biosciences Daily ,

Castle Biosciences, Inc. (NASDAQ:CSTL) Director Sells $138,118.75 in Stock

Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) Director Daniel Bradbury sold 6,875 shares of the company’s stock in a transaction that occurred on Friday, December 8th. The shares were sold at an average price of $20.09, for a total transaction of $138,118.75. Following the completion of the sale, the director now directly owns 50,605 […] ....

Daniel Bradbury , Castle Biosciences , Castle Biosciences Inc , Royal Bank , Assetmark Inc , Bluepath Capital Management , Tower Research Capital , Osaic Holdings Inc , Securities Exchange Commission , Get Free Report , Director Daniel Bradbury , Exchange Commission , Path Capital Management , Research Capital , Castle Biosciences Daily , Nasdaq Cstl , Insider Trading , Nsider Trades ,